TrialCirculation. Cardiovascular genetics2015

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody.

Paul N Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.